Jerusalem: On Dec 29, Israel’s Oramed Pharmaceuticals announced that its Oravax Medical unit had signed a deal with Vietnam’s Tan Thanh Holdings for the pre-order of 10 million doses of its oral COVID-19. The said COVID-19 vaccine is in clinical trials. Nadav Kidron, chief executive of Oramed, said its oral COVID vaccine was undergoing Phase I clinical trials, and results should be available in early 2022.

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Egypt pledges support for Lebanon as Israeli strikes continue

Egypt has pledged to provide political and humanitarian support to Lebanon as…

Atif Mian criticizes PTI’s economic policies

On Sunday, renowned Pakistani-American economist Atif Mian said that Imran Khan inherited…

Iran warns France over ‘insulting’ Khamenei caricatures

Iran has warned France of consequences after the notorious magazine Charlie Hebdo…

Israel launches massive attacks in Lebanon against Hezbollah-affiliated bank

At least 11 Israeli air strikes have hit the southern suburbs of…